Page last updated: 2024-10-27

fleroxacin and Endocarditis, Bacterial

fleroxacin has been researched along with Endocarditis, Bacterial in 2 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Endocarditis, Bacterial: Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaatz, GW2
Seo, SM2
Barriere, SL2
Albrecht, LM2
Rybak, MJ2

Other Studies

2 other studies available for fleroxacin and Endocarditis, Bacterial

ArticleYear
Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:8

    Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Fleroxacin; Male; Methicillin; Methici

1991
Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:4

    Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fleroxacin; Male; Methi

1989